Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

Inclusion Criteria: * Diagnosis of non-infectious uveitis (pan, anterior, intermediate and posterior) * Diagnosis of macular edema associated with non-infectious uveitis (retinal thickness ≥ 300 microns) * Visual Acuity score of ≥ 5 letters read (20/800 Snellen equivalent) and ≤ 70 letters read (20/40 Snellen equivalent), in the study eye Exclusion Criteria: * Any active ocular disease or infection in the study eye other than uveitis * Intraocular pressure \> 22 mmHg or uncontrolled glaucoma in the study eye; subjects are not excluded if IOP ≤ 22 mmHg with no more than 2 IOP lowering medications. * Any uncontrolled systemic disease that, in the opinion of the Investigator, would preclude participation in the study * Any topical ocular corticosteroid in the 10 days prior to baseline; intraocular or periocular corticosteroid injections in the 2 months prior to baseline; an OZURDEX implant in the 6 months prior to baseline; RETISERT or ILUVIEN implant in the 3 years prior to baseline.